Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas
Nitya Raj, Jennifer A. Chan, Stephanie J. Wang, Rahul Aggarwal, Susan Calabrese, April DeMore, Lawrence Fong, Jennifer A. Grabowsky, Thomas A. Hope, K. Kolli, Claire K. Mulvey, Pamela N. Münster, Kimberly Perez, Sippy Punn, Diane Reidy‐Lagunes, Sofia Von Fedak, Li Zhang, Emily K. Bergsland
Topics & Concepts
PembrolizumabMedicineInternal medicineChemotherapyOncologyResponse Evaluation Criteria in Solid TumorsAdverse effectGastroenterologyImmunotherapyCancerProgressive diseaseNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesThyroid Cancer Diagnosis and Treatment